Macter International Proposes 5-for-1 Share Split
Macter International Limited has proposed subdividing its shares by reducing their face value from Rs.
Macter International Limited has proposed subdividing its shares by reducing their face value from Rs.
Article outline
- What happened
- What comes next
- The key numbers
- The details
- The bottom line
Key points
- Only 2 New Retailers Join Tax Net Under Govt's Fixed Tax Scheme.
- Macter's share count will growth from 45, 811, 018 ordinary shares of Rs.
- Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.
- Add as a preferredSource on Google Follow on Google News Join WhatsApp.
Macter International Limited has proposed subdividing its shares by reducing their face value from Rs. 10 to Rs. 2 per share, a move aimed at improving market liquidity and making the stock more accessible to investors.
For context, the proposal was considered by the company's Board of Directors at a session on September 22 and will be presented to shareholders for approval at the upcoming Annual General Gathering, subject to regulatory approvals.
Under the proposed subdivision, each existing ordinary share of Rs. 10 will be converted into five ordinary shares of Rs. 2 each. The company's total issued, subscribed and paid-up capital will remain unchanged.
Macter's share count will growth from 45, 811, 018 ordinary shares of Rs. 10 each to 229, 055, 090 ordinary shares of Rs. 2 each.
Shareholders holding one ordinary share of Rs. 10 on the effective date will receive five ordinary shares of Rs. 2 each under the proposed arrangement.
Notably, the firm stated the subdivision is intended to enhance market liquidity, improve investor accessibility and align Macter's stock cost with broader market participation. Macter International Limited is a Pakistani pharmaceutical firm incorporated in 1992 with its shares listed on the Pakistan Stock Exchange since 2017.
Meanwhile, the firm manufactures and markets pharmaceutical products throughout a broad set of dosage forms, including tablets, capsules, syrups, injectables, creams and inhalers, and is additionally a major contract manufacturer for international healthcare businesses. Stay Connected with ProPakistani.
Obtain the latest business news, market insights, and economic updates wherever you prefer. Follow on Google Discover.
In short, macter International Proposes 5-for is the central thread here, and readers can expect follow-up reporting as the picture becomes clearer.
